Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide

By Eastell R.   Rogers A.   Ni X.   Krege J.  

Osteoporosis International, Vol. 22, Iss. 6, 2011-06 ,pp. : 1927-1934

Springer Publishing Company

Access to resources Recommend Favorite

Effects of alendronate on the peri‐implant bone in rats

By  

ORAL DISEASES, Vol. 21, Iss. 2, 2015-03 ,pp. : 248-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation

By Leist Thomas P.   Vermersch Patrick  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2667-2676

Informa Healthcare

Access to resources Recommend Favorite

Population pharmacokinetic analysis of the microemulsion formulation of cyclosporin A (Neoral^®®) in renal transplant patients

By Xuan Dawei   Nightingale Charles H   Hull David   Nicolau David P  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 259-264

Future Medicine

Access to resources Recommend Favorite

Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine

By Barbanti Piero   Carpay Johannes A.   Kwong W. Jacqueline   Ahmad Faiz   Boswell Diane  

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2021-2029

Informa Healthcare

Access to resources Recommend Favorite